Vascular system-central veins, percutaneous approach

85815700 Category Share

Vascular system-central veins, percutaneous approach is an EFRIS commodity class (code 85815700) under Administrative interventions or procedures, physiological systems and anatomical regions, introduction and irrigation and circulatory in Uganda Revenue Authority's e-invoicing system.

29 items in this category

• 85815708Introduction of analgesics, hypnotics, sedatives into central vein, percutaneous approach
  Exempt
• 85815718Introduction of anti-inflammatory into central vein, percutaneous approach
  Exempt
• 85815706Introduction of antiarrhythmic into central vein, percutaneous approach
  Exempt
• 85815712Introduction of blood brain barrier disruption substance into central vein, percutaneous approach
  Exempt
• 85815722Introduction of clofarabine into central vein, percutaneous approach
  Exempt
• 85815705Introduction of destructive agent into central vein, percutaneous approach
  Exempt
• 85815715Introduction of electrolytic and water balance substance into central vein, percutaneous approach
  Exempt
• 85815711Introduction of glucarpidase into central vein, percutaneous approach
  Exempt
• 85815726Introduction of high-dose interleukin-2 into central vein, percutaneous approach
  Exempt
• 85815703Introduction of human b-type natriuretic peptide into central vein, percutaneous approach
  Exempt
• 85815728Introduction of immunostimulator into central vein, percutaneous approach
  Exempt
• 85815727Introduction of immunosuppressive into central vein, percutaneous approach
  Exempt
• 85815704Introduction of insulin into central vein, percutaneous approach
  Exempt
• 85815714Introduction of intracirculatory anesthetic into central vein, percutaneous approach
  Exempt
• 85815725Introduction of low-dose interleukin-2 into central vein, percutaneous approach
  Exempt
• 85815723Introduction of monoclonal antibody into central vein, percutaneous approach
  Exempt
• 85815716Introduction of nutritional substance into central vein, percutaneous approach
  Exempt
• 85815719Introduction of other anti-infective into central vein, percutaneous approach
  Exempt
• 85815724Introduction of other antineoplastic into central vein, percutaneous approach
  Exempt
• 85815709Introduction of other diagnostic substance into central vein, percutaneous approach
  Exempt
• 85815702Introduction of other hormone into central vein, percutaneous approach
  Exempt
• 85815713Introduction of other therapeutic substance into central vein, percutaneous approach
  Exempt
• 85815721Introduction of other thrombolytic into central vein, percutaneous approach
  Exempt
• 85815720Introduction of oxazolidinones into central vein, percutaneous approach
  Exempt
• 85815707Introduction of platelet inhibitor into central vein, percutaneous approach
  Exempt
• 85815710Introduction of radioactive substance into central vein, percutaneous approach
  Exempt
• 85815729Introduction of recombinant human-activated protein c into central vein, percutaneous approach
  Exempt
• 85815717Introduction of serum, toxoid and vaccine into central vein, percutaneous approach
  Exempt
• 85815701Introduction of vasopressor into central vein, percutaneous approach
  Exempt